Skip to search formSkip to main contentSkip to account menu

Arimidex

Known as: Astra brand of anastrozole, AstraZeneca brand of anastrozole, Zeneca brand of anastrozole 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

anastrozole
anastrozole 1 MG Oral Tablet [Arimidex]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
The effects of anastrozole on the proliferation of FM3A cells.
PURPOSE In this study, the antiproliferative effects of the aromatase inhibitor anastrozole (arimidex®) was evaluated on estrogen… 
2010
2010
The ATAC adjuvant breast-cancer trial: Six-year results of the endometrial subprotocol
Postmenopausal women with localised, early breast cancer (n = 285) were enrolled in a prospective subprotocol of the ‘arimidex… 
2009
2009
Results of randomized phase II trial combining Iressa® (gefitinib) and arimidex in women with advanced breast cancer (ABC). EORTC protocol 10021.
CTRC-AACR San Antonio Breast Cancer Symposium: 2008 Abstracts Abstract #6133 Background: Preclinical data suggest that EGFR… 
Review
2008
Review
2008
Clinical trial presentations, agency guidelines, and oncology practice: findings from the arimidex, tamoxifen, alone or in combination trial.
PURPOSE Our objective was to explore the potential influence of agency guidelines/technology assessments regarding anastrozole… 
2005
2005
Benzofuran- and furan-2-yl-(phenyl)-3-pyridylmethanols: Synthesis and inhibition of P450 aromatase
A series of benzofuran-2-yl-(phenyl)-3-pyridylmethanol derivatives were prepared using an efficient 1-step procedure in good… 
2004
2004
Arimidex inhibition on proliferation of human breast solid tumors measured by ATP bioluminescence.
2003
2003
Effects of Exercise Training on Fasting Insulin , Insulin Resistance , Insulin-like Growth Factors , and Insulin-like Growth Factor Binding Proteins in Postmenopausal Breast Cancer Survivors : A…
Insulin, insulin-like growth factors (IGFs) I and II, and IGF binding proteins (IGFBPs) 1 and 3 have been implicated in breast… 
2001
2001
Combined use of goserelin (zoladex) and anastrozole (arimidex) as second-line endocrine therapy in premenopausal women with advanced breast cancer — a study of its clinical and endocrine effects
1998
1998
Effect of dual inhibition of 5‐alpha‐reductase and aromatase on spontaneously developed canine prostatic hypertrophy
Our aim was to assess the effect of dual inhibition of 5‐alpha‐reductase and aromatase on prostate glands. 
1995
1995
104. Randomized phase III study of the new selective aromatase inhibitor arimidex (A) (ZD1033) versus megestrol acetate (MA) in the treatment of postmenopausal women with advanced breast cancer
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)